irbesartan winthrop irbesartan 300 mg film-coated tablet blister pack
sanofi-aventis australia pty ltd - irbesartan -
irbesartan winthrop irbesartan 150 mg film-coated tablet blister pack
sanofi-aventis australia pty ltd - irbesartan -
irbesartan winthrop irbesartan 75 mg film-coated tablet blister pack
sanofi-aventis australia pty ltd - irbesartan -
irbesartan mylan irbesartan 300 mg tablet blister pack
viteia pty ltd - irbesartan, quantity: 300 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; povidone; lactose monohydrate; titanium dioxide; hypromellose; macrogol 4000 - irbesartan mylan is indicated for the treatment of hypertension., irbesartan mylan is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (> 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
irbesartan mylan irbesartan 150 mg tablet blister pack
viteia pty ltd - irbesartan, quantity: 150 mg - tablet - excipient ingredients: povidone; lactose monohydrate; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; macrogol 4000 - irbesartan mylan is indicated for the treatment of hypertension., irbesartan mylan is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (> 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
irbesartan mylan irbesartan 75 mg tablet blister pack
viteia pty ltd - irbesartan, quantity: 75 mg - tablet - excipient ingredients: croscarmellose sodium; lactose monohydrate; povidone; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 4000 - irbesartan mylan is indicated for the treatment of hypertension., irbesartan mylan is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (> 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
irbesartan an irbesartan 300mg film-coated tablet blister pack
amneal pharma australia pty ltd - irbesartan -
irbesartan an irbesartan 150mg film-coated tablet blister pack
amneal pharma australia pty ltd - irbesartan -
irbesartan an irbesartan 75mg film-coated tablet blister pack
amneal pharma australia pty ltd - irbesartan -
irbesartan mylan irbesartan 300 mg tablet bottle
alphapharm pty ltd - irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - irbesartan mylan is indicated for the treatment of hypertension., irbesartan mylan is indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (> 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.